Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06251050 | A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing Radiotherapy | completed | Phase 1 / Phase 2 | 175 | West China HospitalOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT07752277 | Quantitative Pharmacology-Based Dose Adjustment Protocol in Postoperative Thyroid Cancer Patients | completed | — | 124 | Zhejiang Provincial People's HospitalOTHER | 1 | Aug 13, 2026 |
| clinicaltrials |
| NCT00936858 | RAD001 for Patients With Radioiodine Refractory Thyroid Cancer | completed | Phase 2 | 50 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT02657551 | A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer | completed | Phase 2 | 17 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT04354246 | COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies | completed | Phase 1 | 94 | Compugen LtdINDUSTRY | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06289049 | Heavy Strength Training in Head and Neck Cancer Survivors(LIFTING2) | completed | Phase 2 | 37 | University of AlbertaOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07496684 | Application and Evaluation of Vision-LSTM Modeling in Diagnostic Ultrasound Imaging of TI-RADS Category 4b Thyroid Nodules | completed | — | 401 | Ma ZheOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT05119036 | Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma | completed | N/A | 82 | Indiana UniversityOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07652450 | Incidental Thyroid Cancer in Cases With Inflammatory Thyroid Lesion(Thyroid cancer) | completed | N/A | 98 | Minia UniversityOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT06145412 | A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer | completed | Phase 2 | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07255482 | Mortality Benefit of Ultrasound for Thyroid Nodules Identified With PET Imaging: Non-Inferiority Emulated Target Trial | completed | — | 874 | Brigham and Women's HospitalOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT03416153 | Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer | completed | Phase 2 | 91 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT06498674 | AI-Assisted Ultrasound Review Before Thyroid Surgery | completed | N/A | 515 | Fujian Medical UniversityOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT06674499 | Development and Evaluation of a Self-Management Model for Cancer Rehabilitation | completed | N/A | 144 | Xingchen PengOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT02489084 | Predictive Models for Radiation-induced Side Effects in Head and Neck Cancer Based on Single Nucleotide Polymorphisms (SNP)(HANS) | completed | — | 2,000 | University Medical Center GroningenOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT05650710 | Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation(ACS) | completed | N/A | 51 | Vanderbilt University Medical CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT02296684 | Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 67 | Washington University School of MedicineOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06681935 | Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery | completed | — | 40 | Medical College of WisconsinOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT00333099 | INEC Study: Immuno-modulating Enteral Nutrition in Cancer | completed | Phase 4 | 250 | University Hospital, Clermont-FerrandOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT03972072 | MRI - Guided Adaptive RadioTHerapy for Reducing XerostomiA in Head and Neck Cancer (MARTHA-trial)(MARTHA) | completed | N/A | 49 | Panagiotis BalermpasOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07741110 | Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy | completed | — | 141 | Hellenic Cooperative Oncology GroupOTHER | 0 | Aug 3, 2026 | clinicaltrials |
| NCT02528955 | De-Intensification Radiotherapy Postoperative Head Neck(DIREKHT) | completed | Phase 2 | 200 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT04290546 | CIML NK Cell in Head & Neck Cancer | completed | Phase 1 | 11 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT06725342 | HNSCC Immuno-genomics Project | completed | — | 401 | Hellenic Cooperative Oncology GroupOTHER | 0 | Jul 29, 2026 | clinicaltrials |
| NCT01833650 | The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer | completed | N/A | 120 | Cyprus University of TechnologyOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT04208490 | Implementation and Effectiveness Trial of HN-STAR(HN-STAR) | completed | N/A | 357 | Wake Forest University Health SciencesOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT04235803 | Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery | completed | N/A | 78 | University of California, San FranciscoOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT05570851 | Alcohol Cessation Among Head and Neck Cancer Survivors | completed | N/A | 126 | Northwell HealthOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT03117946 | Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy(i-RTCT) | completed | N/A | 136 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT05005715 | Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery | completed | Phase 2 | 64 | Seoul National University HospitalOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT00076310 | OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer | completed | Phase 2 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT03729518 | TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck | completed | N/A | 150 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT06666634 | Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy(NANOSCAN) | completed | N/A | 29 | The Netherlands Cancer InstituteOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT01302834 | Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer | completed | Phase 3 | 987 | Radiation Therapy Oncology GroupNETWORK | 2 | Jul 20, 2026 | clinicaltrials |
| NCT04139096 | Genetic Susceptibility to Radiation Induced Thyroid Cancer | completed | — | 60 | Institut National de la Santé Et de la Recherche Médicale, FranceOTHER_GOV | 1 | Jul 20, 2026 | clinicaltrials |
| NCT06307093 | Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms | completed | Phase 1 | 90 | R-PharmINDUSTRY | 1 | Jul 15, 2026 | clinicaltrials |
| NCT02724488 | Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies(SPECIAL) | completed | — | 14 | University Health Network, TorontoOTHER | 0 | Jul 14, 2026 | clinicaltrials |
| NCT07435324 | A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma | completed | Phase 3 | 161 | R-PharmINDUSTRY | 2 | Jul 14, 2026 | clinicaltrials |
| NCT07701226 | Novel Tracheostomy Tube Fixation Device in Oral Cancer Patients | completed | N/A | 150 | Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT07695974 | Clinicopathological Predictors of Recurrence in Papillary Thyroid Carcinoma | completed | — | 1,113 | University of Roma La SapienzaOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT06958601 | Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer | completed | — | 430 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT00942734 | Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT03345563 | Project HERO: Health Empowerment & Recovery Outcomes(HERO) | completed | N/A | 113 | Rutgers, The State University of New JerseyOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT04246697 | Multimodal Pain Study in Free Flap Patients | completed | Phase 4 | 30 | University of Kansas Medical CenterOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT05751486 | A Clinical Study to Evaluate the Safety and Tolerability of JS001sc in Advanced Nasopharyngeal Carcinoma | completed | Phase 1 | 64 | Shanghai Junshi Bioscience Co., Ltd.OTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT04609566 | Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors | completed | Phase 2 | 161 | Seagen, a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 6, 2026 | clinicaltrials |
| NCT01813136 | Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma | completed | Phase 2 | 168 | Centre Leon BerardOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT04000880 | Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health(AMPLIFY) | completed | N/A | 603 | University of Alabama at BirminghamOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07682285 | Taiwanese Green Propolis for Lipid Profiles, Fatigue, and Quality of Life in Oral Cavity Cancer Survivors(TGP-OCS) | completed | N/A | 25 | Taipei Medical UniversityOTHER | 1 | Jul 2, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 13, 2026source: clinicaltrials